Twist Bioscience Corp

Healthcare US TWST

45.4USD
-0.12(0.26%)

Last update at 2024-11-08T21:00:00Z

Day Range

44.7946.55
LowHigh

52 Week Range

14.4250.50
LowHigh

Fundamentals

  • Previous Close 45.52
  • Market Cap2471.11M
  • Volume638441
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-161.17501M
  • Revenue TTM277.49M
  • Revenue Per Share TTM4.83
  • Gross Profit TTM 84.23M
  • Diluted EPS TTM-3.38

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax -203.46600M -228.27400M -154.02800M -139.54900M -107.37700M
Minority interest - - - - -
Net income -204.61800M -217.86300M -152.09800M -139.93100M -107.66900M
Selling general administrative 189.74M 212.95M 135.90M 103.27M 80.13M
Selling and marketing expenses - - - - -
Gross profit 89.73M 84.23M 51.71M 28.69M 6.96M
Reconciled depreciation - 16.51M 9.75M 6.68M 6.11M
Ebit -217.15900M -249.02100M -153.26000M -117.57900M -108.85000M
Ebitda -193.20500M -247.04600M -154.19500M -116.26200M -106.08300M
Depreciation and amortization 23.95M 1.98M -0.93500M 1.32M 2.77M
Non operating income net other - 6.58M -0.93500M 1.32M 2.77M
Operating income -217.15900M -249.02100M -153.26000M -117.57900M -108.85000M
Other operating expenses 452.01M 452.59M 285.59M 207.68M 163.24M
Interest expense 0.00500M 0.08M 0.37M 0.79M 1.29M
Tax provision 1.15M -10.41100M -1.93000M 0.38M 0.29M
Interest income 14.37M 3.06M 0.43M 1.50M 3.03M
Net interest income 14.36M 2.98M 0.07M 0.71M 1.74M
Extraordinary items - - - - -
Non recurring - - - 22.50M -
Other items - - - - -
Income tax expense 1.15M -10.41100M -1.93000M 0.38M 0.29M
Total revenue 245.11M 203.56M 132.33M 90.10M 54.38M
Total operating expenses 296.63M 333.26M 204.97M 146.27M 115.81M
Cost of revenue 155.38M 119.33M 80.62M 61.41M 47.43M
Total other income expense net -10.92300M 20.75M -0.76800M -21.97000M 1.47M
Discontinued operations - - - - -
Net income from continuing ops -204.61800M -217.86300M -152.09800M -139.93100M -107.66900M
Net income applicable to common shares - -217.86300M -152.09800M -139.93100M -107.66900M
Preferred stock and other adjustments - - - - -
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Total assets 776.40M 961.38M 702.10M 398.88M 186.99M
Intangible assets 54.48M 59.74M 18.26M 0.31M 0.51M
Earning assets - - - - -
Other current assets 11.72M 11.91M 8.28M 6.20M 2.59M
Total liab 152.97M 171.99M 121.28M 62.62M 34.91M
Total stockholder equity 623.43M 789.38M 580.82M 336.26M 152.08M
Deferred long term liab - - - - -
Other current liab 7.80M 53.45M 9.62M 2.61M 0.82M
Common stock - 789.38M 580.82M 336.26M -186.99400M
Capital stock - 0.00000M 0.00000M 0.00000M 0.00000M
Retained earnings -1033.03400M -828.41600M -610.55300M -458.45500M -318.52400M
Other liab - 0.06M 5.07M 0.35M 0.16M
Good will 85.81M 85.81M 22.43M 1.14M 1.14M
Other assets - -0.00100M 49.90M 3.40M 4.38M
Cash 286.47M 378.69M 465.83M 93.67M 46.73M
Cash and equivalents - - - - -
Total current liabilities 73.32M 90.66M 63.05M 36.03M 30.35M
Current deferred revenue 36.57M 3.48M 28.76M 18.85M 16.44M
Net debt -192.40100M -283.77500M -402.90800M -57.68500M -39.00200M
Short term debt 14.90M 13.64M 9.77M 9.74M 3.33M
Short long term debt - - 1.55M 3.33M 3.33M